Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-11-17
1995-09-05
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544360, 544295, 544357, A61K 31495, C07D40104, C07D40304, C07D24102
Patent
active
054479312
ABSTRACT:
New therapeutic use of some heterocyclylpiperazines of formula (I) ##STR1## wherein R represents hydrogen or (C.sub.1 -C.sub.4)alkyl, R.sub.1 represents hydrogen or a methyl group, R.sub.2 represents hydrogen or a halogen atom; X et Y represent each --CH.dbd., or one is --CH.dbd. and the other is --N.dbd., as well as their pharmaceutically acceptable salts for the preparation of a medicament for the treatment or prophylaxis of the pathological conditions which can be improved by 5-HT.sub.3 mediated selective agonism and new compounds deriving from this chemical class.
REFERENCES:
patent: 2562036 (1951-07-01), Hultquist et al.
patent: 2606906 (1952-08-01), Hultquist et al.
patent: 4078063 (1978-03-01), Lumma, Jr. et al.
patent: 4081542 (1978-03-01), Lumma, Jr. et al.
patent: 4163849 (1979-08-01), Lumma, Jr. et al.
patent: 4442103 (1984-04-01), Saari
Cignarella et al., Farmaco Ed. Sci., 34(9), 1979, pp. 817-823.
Regnier et al., J. Med. Chem. 11(6), 1968, 1151-1155.
Saari et al., J. Med. Chem., 26(12), 1983, 1696-1701.
Croci et al., J. Pharm. Pharmacol., 44(4), 1992, 358-360.
Patel et al., Indian J. Physiol. Pharmacol. 25(4), 1981, 379-384.
Phychopharmacol. Bull. 27(2), 1991, 163-170.
Bianchi et al., Eur. J. Pharmacol., 147(3), 1988, 343-350.
Bianchi et al., Eur. J. Pharmacol. 151(3), 1988, 365-371.
Glennon et al., Eur. J. Pharmacol., 168(3), 1989, 387-392.
Baroni Marco
Giudice Antonina
Guzzi Umberto
Landi Marco
Sanofi
Tsang Cecilia
LandOfFree
New therapeutic use of heterocyclylpiperazines as 5-HT.sub.3 ago does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New therapeutic use of heterocyclylpiperazines as 5-HT.sub.3 ago, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New therapeutic use of heterocyclylpiperazines as 5-HT.sub.3 ago will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-472909